Histone deacetylases play distinct roles in telomeric VSG expression site silencing in African trypanosomes by Wang, Qiao-Ping et al.
Histone deacetylases play distinct roles in telomeric VSG
expression site silencing in African trypanosomesmmi_7284 1237..1245
Qiao-Ping Wang,1,2 Taemi Kawahara1 and
David Horn1*
1London School of Hygiene and Tropical Medicine,
Keppel Street, London WC1E 7HT, UK.
2Center for Parasitic Organisms, State Key Laboratory
of Biocontrol, School of Life Sciences, Key Laboratory
of Tropical Diseases Control, Ministry of Education,
Zhongshan Medical College, Sun Yat-Sen University,
Guangzhou 510275, China.
Summary
African trypanosomes evade the host immune
response through antigenic variation, which is
achieved by periodically expressing different variant
surface glycoproteins (VSGs). VSG expression is
monoallelic such that only one of approximately 15
telomeric VSG expression sites (ESs) is transcribed
at a time. Epigenetic regulation is involved in VSG
control but our understanding of the mechanisms
involved remains incomplete. Histone deacetylases
are potential drug targets for diseases caused by pro-
tozoan parasites. Here, using recombinant expres-
sion we show that the essential Trypanosoma brucei
deacetylases, DAC1 (class I) and DAC3 (class II)
display histone deacetylase activity. Both DAC1 and
DAC3 are nuclear proteins in the bloodstream stage
parasite, while only DAC3 remains concentrated in
the nucleus in insect-stage cells. Consistent with
developmentally regulated localization, DAC1 antago-
nizes SIR2rp1-dependent telomeric silencing only in
the bloodstream form, indicating a conserved role in
the control of silent chromatin domains. In contrast,
DAC3 is speciﬁcally required for silencing at VSG ES
promoters in both bloodstream and insect-stage
cells. We conclude that DAC1 and DAC3 play distinct
roles in subtelomeric gene silencing and that DAC3
represents the ﬁrst readily druggable target linked to
VSG ES control in the African trypanosome.
Introduction
Trypanosoma brucei is a mono-ﬂagellated parasitic pro-
tozoan that causes sleeping sickness in humans and
Nagana in cattle. T. brucei branched very early from the
eukaryotic lineage and displays some unusual features
such as polycistronic transcription of protein-coding
genes (Vanhamme et al., 2001). The T. brucei
bloodstream-form cell surface comprises a dense variant
surface glycoprotein (VSG) coat, encoded in a polycis-
tronically transcribed telomeric VSG expression site
(ES), which can periodically change to evade host
immune defences (Pays, 2005). Although there are
approximately 15 different telomeric VSG ESs, only one
at a time is transcriptionally active (Hertz-Fowler et al.,
2008). The mechanism underlying this monoallelic VSG
expression remains unknown, although the telomeric
location and chromatin remodelling appear to be
involved; a telomere-binding protein known as repressor/
activator protein 1 and a member of the ISWI family of
SWI2/SNF2-related chromatin-remodelling complexes
(ISWI) are required for efficient VSG ES silencing
(Hughes et al., 2007; Yang et al., 2009). In addition, a
dispensable histone methyltransferase (DOT1B) has a
lesser role in VSG ES silencing, and is required for rapid
transcriptional switching among ESs (Figueiredo et al.,
2008).
Histone post-translational modiﬁcations (PTMs), in the
N-terminal tails of histones in particular, play essential
roles in chromatin assembly, DNA replication, recombi-
nation and repair, and transcriptional regulation (Groth
et al., 2007; Kouzarides, 2007). Although T. brucei his-
tones are divergent compared with other eukaryotes,
several residues are acetylated or methylated and the
functions of these PTMs may be conserved (Horn, 2007;
Figueiredo et al., 2009). These histone PTMs are
dynamically regulated by pairs of histone-modifying
enzymes (Kouzarides, 2007). For example, histone
deacetylases (HDACs) can reverse acetylation mediated
by histone acetyltransferases (Drummond et al., 2005).
HDACs participate in various forms of transcription
repression such as telomere position effect in the yeast,
Saccharomyces cerevisiae (DeRubertis et al., 1996;
Rundlett et al., 1996), position-effect variegation in
Drosophila (Rundlett et al., 1996) and X-chromosome
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HDACs are also involved in many cancers and have
emerged as drug targets for chemotherapy (Drummond
et al., 2005). A large number of HDAC inhibitors have
been developed, and related compounds now show
potential for the treatment of diseases caused by proto-
zoan parasites (Bougdour et al., 2009).
The roles of the T. brucei class III, Sir2-related deacety-
lases have been explored and it has been demonstrated
that SIR2rp1, the only nuclear protein of this class in T.
brucei, is required for basal telomeric silencing, but not for
VSG ES silencing (Alsford et al., 2007). There are also
four putative zinc-dependent, class I–II HDACs in T.
brucei (Ingram and Horn, 2002), including DAC1 and
DAC3, which appear to be essential for growth in the
bloodstream form. In this study, we characterize these
HDACs and demonstrate distinct roles in telomeric and
VSG ES silencing.
Results
DAC1 and DAC3 are nuclear proteins
To determine the sites of action of the various T. brucei
DACs in trypanosomes, we initially established strains
conditionally expressing N-terminally tagged versions of
each protein (Fig. 1A). Interestingly, because we were
particularly interested in the essential DAC1 and DAC3 as
potential drug targets, MYCDAC1 and GFPDAC3 both accu-
mulate in the nucleus, while MYCDAC2 and MYCDAC4 are
distributed more widely and appear to be predominantly
cytoplasmic (Fig. 1B); uninduced cells were consistently
negative for GFP (data not shown). Further studies there-
fore focused on the essential, nuclear DACs. For the
purposeofmonitoringproteinexpressionduringRNAinter-
ferenceknockdown(seebelow),weintegratedGFPtagsat
the DAC1 and DAC3 chromosomal loci in bloodstream-
form cells. In this case, GFPDAC1 and GFPDAC3 were
Fig. 1. DAC1 and DAC3 are nuclear proteins.
A. Western blot detection of tagged DACs 1–4 (arrowheads). The DACs were conditionally expressed from an ectopic locus in
bloodstream-form cells. Cells were either cultured without Tet (-) or induced for 24 h with Tet (+,1mgm l
-1). DACs 1–4 were predicted to be
43, 61, 75 and 64 kDa polypeptides respectively. DAC1 was fused to 12xMYC, while DAC2 and DAC4 were fused to a single MYC tag. DAC3
was fused to GFP. The Coomassie panels serve as loading controls.
B. Immunoﬂuorescence analysis. N, nucleus; K, kinetoplast (mitochondrial DNA). Other details as in A. GeneIDs: DAC1; Tb927.10.1680;
DAC2, Tb11.01.7240; DAC3, Tb927.2.2190; DAC4, Tb927.5.2900.
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again, both proteins accumulated in the nucleus in
bloodstream-form cells (Fig. S1 and see below).
DAC1 and DAC3 display HDAC activity
We demonstrated above that DAC1 and DAC3 are
nuclear proteins in the bloodstream form. To determine
whether these DACs display HDAC activity, we expressed
recombinant DAC1 and DAC3 in Escherichia coli. Active,
soluble DAC1 was obtained as an N-terminal MBP-fusion
protein, whereas DAC3 was obtained as an N-terminal
6xHis-fusion protein. MBPDAC1 and HISDAC3 were puriﬁed
by affinity chromatography (Fig. S2) and HDAC activity
was determined using an in vitro assay. Both proteins
displayed HDAC activity (Fig. 2A and B), which may be
relatively lower for DAC1 due to the presence of additional
products in this preparation (Fig. S2A). Class I–II HDACs
are zinc-dependent enzymes with conserved zinc-binding
residues located at the base of the catalytic pocket;
one His and two Asn residues participate in zinc-ion
binding (Finnin et al., 1999). The purity and yield of the
DAC3 preparation facilitated mutagenesis studies and by
sequence alignment, residues Asn314,H i s 316 and Asn582 in
DAC3 were predicted to be these zinc ligands (Ingram
and Horn, 2002). An H316A mutation (Figs 2C and S2C)
abolished HDAC activity indicating that this residue is
critical for the deacetylase activity of DAC3 (Fig. 2D).
DAC1 antagonizes basal telomeric silencing
In trypanosomes, many silent VSG genes are located at
the telomeric end of polycistronic ESs. These transcription
units have promoters that, unusually, recruit RNA poly-
merase I and are often located ~50 kbp from the telomere.
A small number of factors have been linked to the
ES promoter silencing process (Hughes et al., 2007;
Figueiredo et al., 2008; Yang et al., 2009), while distinct
factors are required for basal telomeric silencing, which
spreads only a few kbp from the telomere (Alsford et al.,
2007; Kawahara et al., 2008). We used an RNA interfer-
ence (RNAi) approach to assess the role of DAC1 and
DAC3 in telomeric silencing. For this assay, hairpin RNAi
knockdown constructs were engineered into a strain
expressing GFPDAC1 or GFPDAC3 from one of the native
alleles. Induction of RNAi against DAC1 or DAC3 leads to
decreased GFPDAC1 or GFPDAC3 expression, respectively,
indicating efficient protein knockdown in both cases
(Fig. 3A). Each knockdown was associated with a growth
defect (Fig. 3B) conﬁrming that DAC1 and DAC3 are
essential for growth in the bloodstream form.
RNAi knockdown was then carried out in strains with an
NPT reporter gene under the control of an rRNA promoter
located within 2 kbp of a telomere (see Fig. 4A). Monitor-
ing of NPT reporter expression revealed an increase in
telomeric silencing speciﬁcally associated with DAC1
knockdown (Fig. 4B) and this ﬁnding was conﬁrmed in an
independent strain (data not shown) indicating that DAC1
antagonizes basal telomeric silencing. DAC1 knockdown
also coincided with a growth defect in the insect stage
(Fig. 4C) but knockdown had no impact on telomeric
silencing in this life-cycle stage (Fig. 4D). This develop-
mental stage-speciﬁc function for DAC1 is consistent with
failure to accumulate in the nucleus in the insect, procyclic
form (Fig. 4E); while GFPDAC3 subcellular localization was
not substantially altered following differentiation (Fig. S1),
Fig. 2. DAC1 and DAC3 display HDAC
activity.
A. DAC1 displayed HDAC activity that was
subject to inhibition by Trichostatin A (TSA,
5 mM). Activity is expressed as OD405 per mg
eluted protein. Assays were done in triplicate
and error bars represent one sd.
B. DAC3 displayed HDAC activity that was
subject to inhibition by TSA (5 mM). Other
details as in A.
C. The conserved zinc-binding residue that
forms part of the HDAC catalytic domain is
indicated. Hs: Homo sapiens; Sc, S.
cerevisiae; Tb, T. brucei. Accession numbers:
ScRPD3, P32561; HsHDA1, P53973.
D. The DAC3
H316A mutation abolishes HDAC
activity. Other details as in A.
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appeared to be predominantly cytoplasmic. Cell cycle
analysis also suggested a defect in DNA replication asso-
ciated with DAC1 knockdown in bloodstream-form cells
(Fig. S3); these cells apparently progress through mito-
chondrial DNA division without DNA replication.
DAC3 is required for VSG ES silencing
There are approximately 15 telomeric and polycistronic
VSG ESs in T. brucei. In bloodstream-form cells, all but
one are reversibly repressed and the frequency of
switching is very low, typically < 10-6 per population
doubling (Horn and Cross, 1997). To determine whether
DAC1 or DAC3 participate in transcriptional repression
at VSG ESs, we generated a strain of T. brucei cells with
a GFP-tagged NPT reporter immediate downstream of a
reversibly silenced VSG ES promoter (Fig. 5A). We
started with cells expressing VSG2, a single copy VSG
on chromosome 6a (Melville et al., 2000). A construct
with a Tet operator and the NPT reporter was integrated
downstream of an active VSG2 ES promoter under tran-
scription permissive conditions. Tet removal allowed the
Tet repressor to bind Tet operator and block VSG2 tran-
scription such that only cells that switch to an alternative
VSG ES survive (Glover et al., 2007); these cells retain
Fig. 3. RNAi conﬁrms that DAC1 and DAC3
are essential for growth in bloodstream-form
trypanosomes.
A. Expression of hairpin DAC1 or DAC3
cassettes triggers speciﬁc RNAi-mediated
knockdown as reported by
GFPDAC1 and
GFPDAC3. The asterisk indicates a
non-speciﬁc band and the Coomassie panels
serve as loading controls.
B. Growth curves for bloodstream-form cells
during DAC1 or DAC3 knockdown (+ Tet).
Four independent strains were analysed for
each DAC. Error bars representing one sd are
obscured by the data points.
Fig. 4. DAC1 antagonizes basal telomeric
silencing in bloodstream-form trypanosomes.
A. The schematic illustrates the NPT reporter
under the control of an rRNA promoter
located within 2 kbp of a telomere.
B. Western blots showing NPT reporter
expression in bloodstream-form cells during
DAC knockdown (+ Tet). The Coomassie
panels serve as loading controls.
C. Growth curve for insect-stage cells during
DAC1 knockdown (+ Tet).
D. Western blots showing NPT reporter
expression in insect-stage cells during DAC1
knockdown (+ Tet). The Coomassie panel
serves as a loading control. The NPT signal
here is stronger than seen in panel B
because telomeric silencing is weaker in
insect-stage cells (Glover and Horn, 2006).
E. Localization of
GFPDAC1 expressed from
the native locus in bloodstream form (BF) and
procyclic form (PF) cells. N, nucleus; K,
kinetoplast (mitochondrial DNA). Bar, 2 mm.
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ES promoter (Fig. 5A). VSG2 ES inactivation and the
capacity for reactivation were conﬁrmed by VSG2
Western blot and GFP-NPT ﬂuorescence analysis (data
not shown).
Subsequently, we integrated the inducible DAC1 or
DAC3 hairpin RNAi knockdown constructs into these
cells. For each experiment, two independent strains were
analysed and results from one of each pair are shown
(Fig. 5B). Expression of the NPT reporter was speciﬁcally
detected following DAC3 knockdown (Fig. 5B) and this
phenotype was conﬁrmed by detection of the GFP-tag on
the NPT reporter (data not shown). Next, we determined
whether DAC3 inﬂuences the silencing of VSG2 located
approximately 60 kbp downstream of the VSG ES pro-
moter (Fig. 5A). Neither VSG2 protein (Fig. 5B) nor
mRNA (Fig. 5C) was detected in the samples that exhib-
ited derepression adjacent to the promoter. These results
indicated that DAC3 depletion led only to derepression at
the VSG ES promoter, and that transcription was subse-
quently attenuated. This phenotype is similar to that
reported for TbISWI knockdown (Hughes et al., 2007) and
is consistent with the idea that additional factors are
involved in VSG ES silencing (Horn, 2009). TbSIR2rp1
mediates basal telomeric silencing, but the effect does not
extend to the VSG ES promoter (Alsford et al., 2007). To
explore the possibility that DAC3 and SIR2rp1 cooperate
to silence VSG ESs, we disrupted both SIR2rp1 alleles in
the DAC3 RNAi strain. These sir2rp1 knockouts were
conﬁrmed by PCR (data not shown). However, expression
of the NPT reporter and VSG2 (Fig. 4D) were similar after
DAC3 knockdown in the SIR2rp1 wild-type and sir2rp1
null strains (compare Fig. 4B and D). Parallel knockdown
of both DAC3 and DAC1 did not lead to derepression of
the NPT reporter (data not shown), suggesting that the
DAC1 defect dominates when both deacetylases are
targeted. Thus, neither SIR2rp1 nor DAC1 appear to
cooperate with DAC3 to silence VSG ESs.
Fig. 5. DAC3 controls VSG ES silencing.
A. The schematic illustrates the silent VSG2
ES with a Tet operator and GFP:NPT reporter
adjacent to a silenced promoter. These
bloodstream-form cells express a second
VSG (X).
B. Western blots showing reporter expression
in bloodstream-form cells during DAC
knockdown (+ Tet). The ‘on’ sample with an
active VSG2 ES serves as a positive control
and the ‘off’ sample serves as a negative
control indicating that the VSG2 ES remains
repressed in the presence of Tet. The
Coomassie panel serves as a loading control.
C. Northern blot for VSG2 expression in
bloodstream-form cells during DAC3
knockdown. The ethidium bromide (EtBr)
panel serves as a loading control.
D. Western blotting showing reporter
expression in sir2rp1 null bloodstream-form
cells during DAC3 knockdown (+ Tet).
E. Growth curve for insect-stage cells during
DAC3 knockdown (+ Tet).
F. Western blots showing NPT expression
during DAC3 knockdown in insect-stage cells.
The Coomassie panel serves as a loading
control.
G. Northern blot for VSG2 expression in
insect-stage cells during DAC3 knockdown.
The EtBr panel serves as a loading control.
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of the VSG2 ES in insect-stage cells, we differentiated the
bloodstream-form DAC3 RNAi strains. DAC3 knockdown
in these cells, once again, lead to a growth defect indicat-
ing that DAC3 expression is also essential for growth in
the insect stage (Fig. 5E). Similar to the situation in
bloodstream-form cells, the NPT reporter was dere-
pressed (Fig. 5F) but VSG2 remained undetectable
(Fig. 5G), indicating that attenuation of transcription
occurs in both life-cycle stages.
Discussion
Previous studies revealed DAC1 and DAC3 as two puta-
tive essential deacetylases in T. brucei (Ingram and Horn,
2002) that are potential targets for chemotherapy (Horn,
2008). In this study, we report characterization of these
enzymes using in vitro HDAC activity assays and func-
tional analysis in trypanosomes. Our results indicate that
both DAC1 and DAC3 display HDAC activity. We further
demonstrate that DAC1 antagonizes telomeric silencing
in bloodstream-form cells, and that DAC3 is required for
VSG ES silencing in both bloodstream and insect-stage
cells.
Based on sequence similarity, cellular localization,
catalytic domain and mechanism of action, HDACs are
divided into four major classes (De Ruijter et al., 2003).
DAC1 and DAC2 are class I, and DAC3 and DAC4 are
class II (Ingram and Horn, 2002). Trypanosomes also
express three class III, Sir2-related deacetylases that are
dispensable for growth; only one of these is a nuclear
protein (Alsford et al., 2007). In human cells, class I
HDACs are typically retained in the nucleus while class II
HDACs are often able to shuttle between nucleus and
cytoplasm (De Ruijter et al., 2003). We show that recom-
binant DAC1 and DAC3 are predominantly nuclear pro-
teins in bloodstream-form trypanosomes, while DAC2
and DAC4 are predominantly cytoplasmic. Interestingly,
DAC1 displays stage-speciﬁc subcellular localization,
relocalizing to the cytoplasm in insect-stage cells.
Histone deacetylases are components of complexes
that play important roles in transcription repression (Yang
and Seto, 2008) and these complexes likely participate
in transcription regulation in trypanosomes (Figueiredo
et al., 2009). For example, histone H4K10 acetylation,
mediated by the histone acetyltransferase, HAT2 (Kawa-
hara et al., 2008), marks the transcriptional start sites for
RNA polymerase II (Siegel et al., 2009). In addition, the
class III deacetylase, SIR2rp1 (Alsford et al., 2007) and
the histone acetyltransferase, HAT1 (Kawahara et al.,
2008) are required for basal telomeric silencing in these
parasites but not for VSG ES silencing. We now show
that DAC1 antagonizes basal telomeric silencing in
bloodstream-form trypanosomes. In support of a speciﬁc
role for DAC1 in this anti-silencing effect, we see that loss
of this phenotype in insect-stage cells coincides with relo-
calization of DAC1 to the cytoplasm in this life-cycle
stage. Interestingly, the class I HDACs, Rpd3 and HDAC1
play a similar telomeric anti-silencing role in yeast (Zhou
et al., 2009) and in Drosophila (Doheny et al., 2008).
Rpd3 has been proposed to mediate this effect by con-
trolling the formation of transcription boundaries, which
prevent Sir2-dependent silencing from spreading into
euchromatic regions (Zhou et al., 2009). Thus, HAT1 and
DAC1 may cooperate to regulate SIR2rp1-mediated
silencing at T. brucei telomeres and this may reﬂect a role
for histone acetylation in boundary element formation that
is conserved from trypanosomes to metazoans. In this
respect, it is also interesting that bloodstream-form cells
defective in either HAT1 (Kawahara et al., 2008) or DAC1
(this report) also display nuclear DNA replication defects;
a proportion of cells progress inappropriately through
mitochondrial DNA division or mitosis in cells depleted for
DAC1 or HAT1 respectively. These results suggest that
the establishment of transcription boundaries is linked to
DNA replication control in trypanosomes. Developmental
control of DAC1 function indicates that the telomeric
boundary is speciﬁc to the bloodstream form.
A small number of factors have now been linked to the
process of telomeric VSG ES silencing and it was
recently reported that nucleosomes are depleted at the
active ES (Figueiredo and Cross, 2010; Stanne and
Rudenko, 2010), but our understanding of the silencing
mechanism remains incomplete. In this study, we dem-
onstrate that DAC3 is required for VSG ES promoter
silencing, but following DAC3 knockdown, transcription
is attenuated through the polycistronic ES. This pheno-
type is observed in both life-cycle stages examined, con-
sistent with the nuclear accumulation of DAC3 in both of
these stages. Notably, a chromatin remodelling factor,
TbISWI, has been linked to similar phenotypes (Hughes
et al., 2007); depletion of TbISWI leads to derepression
of a silent VSG ES promoter, but no derepression of
VSGs at the distal end of the ES. This is consistent with
the idea that ISWI remodelers organize nucleosomes at
inactive regions lacking acetylation (Corona et al., 2002)
but what factors are responsible for transcription attenu-
ation within VSG ESs in the absence of TbISWI or
DAC3? Our data indicate that neither SIR2rp1 nor DAC1
are required for this attenuation in DAC3-depleted cells.
In fact, the only factors linked to transcription repression
throughout the ES are repressor/activator protein 1
(Yang et al., 2009) and DOT1B (Figueiredo et al., 2008).
Thus, transcription attenuation in cells depleted of DAC3
or TbISWI is likely to be dependent upon the action of
these factors.
Histone deacetylases have emerged as potential new
drug targets in protozoan parasites. Our study reveals
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distinct functions in antagonizing basal telomeric silencing
and facilitating telomeric VSG ES silencing. These ﬁnd-
ings provide a mechanistic basis for the development of
new parasite deacetylase inhibitors.
Experimental procedures
T. brucei growth and manipulation
All cells were derived from T. brucei Lister 427 bloodstream-
form MITat1.2 (clone 221a). The bloodstream-form cells were
grown in HMI-11, transformed with linear DNAconstructs and
differentiated to the insect stage in DTM as described
(Alsford et al., 2005; 2007). Drugs were added 6 h post trans-
fection at the following concentrations: phleomycin (CayLa),
2 mgm l
-1; hygromycin (Sigma), 2.5 mgm l
-1; blasticidin (Invit-
rogen), 10 mgm l
-1; G418 (MBI Fermentas), 2 mgm l
-1. Induc-
tion was carried out using tetracycline (Sigma) at 1 mgm l
-1.
Cell counts were carried out using a haemocytometer. Cell
cycle analysis and ﬂow cytometry were carried out as
described (Kawahara et al., 2008).
Plasmid construction
Genes or gene fragments were ampliﬁed by PCR from
genomic DNA clones using Fusion high ﬁdelity DNA poly-
merase (NEB) and speciﬁc oligonucleotides. pMalc2x (NEB)
and pTrcHis-C (Invitrogen) were used for DAC1 and DAC3
expression in E. coli respectively. pRPa
TAGx, pNAT
GFPx and
pRPa
iSL were used for expression of N-terminal fusion pro-
teins and for hairpin RNAi respectively (Alsford and Horn,
2008). piGFP:NPT was derived from piRFP:PAC (Glover
et al., 2007). Brieﬂy, PAC was replaced by NPT using diges-
tion with NotI and ClaI, and RFP was replaced by GFP using
digestion with NotI and HindIII. NPT- and BLA-targeting
constructs (Alsford et al., 2007) were used for SIR2rp1
disruption. Site-directed mutagenesis was carried out using
the QuikChange kit according to the manufactures’ instruc-
tion (Stratagene). Brieﬂy, 35 ng of pTrcHis-DAC3 was used
as a template and 2.5 U of PfuUltra high-ﬁdelity DNA poly-
merase was used for ampliﬁcation. PCR was run as follows:
initially 95°C for 30 s; then 16 cycles of 95°C for 30 s, 55°C
for 60 s, 68°C for 6 min; and ﬁnal extension 5 min at 72°C.
PCR product was digested with 10 U of DpnI to remove the
template. The digested mixture was cleaned with StrataClean
resin (Stratagene) and transfected into XL1-Blue E. coli by
electroporation. pTrcHisDAC3
H316A mutant clones were con-
ﬁrmed by sequencing. All oligonucleotide sequences are
available upon request.
Expression in E. coli and puriﬁcation
For
MBPDAC1 expression and puriﬁcation, pMalc2x-DAC1
was transformed into the protease-deﬁcient strain, ER2508
(NEB) and cells at an OD600 of 0.5 were induced with 0.3 mM
IPTG for 4 h. Protein puriﬁcation was carried out according to
standard procedures (NEB). For
HISDAC3 and
HISDAC3
H316A
mutant expression and puriﬁcation, pTrcHis-DAC3 and
pTrcHis-DAC3
H316A were transformed into the BL21 strain
(Invitrogen) and cells at an OD600 of 0.6 were induced with
1 mM IPTG for 2 h. Protein puriﬁcation was carried out
according to standard procedures (Qiagen). Protein concen-
trations were determined using the BCA protein assay kit
(Thermo scientiﬁc). Proteins were stored in elution buffer plus
1 mM DTT and 10% glycerol at -80°C.
HDAC activity assay
DAC1 and DAC3 activity assays were carried out by HDAC
Colorimetric Assay, Drug Discovery Kit according to the
manufacturer’s instructions (Biomol). Brieﬂy, 20 ml assay
buffer and 5 ml puriﬁed protein were added to a 96-well plate,
and then 25 ml substrate was added and mixed thoroughly
(ﬁnal concentration is 0.5 mM). Following incubation at 37°C
for 30 min, 50 ml developer solution was added and incubated
for another 10 min prior to reading the OD at 405 nm.
DNA and RNA analysis
DNA sequencing was performed using a Thermo Sequenase
dye terminator Kit (Applied Biosystems), a thermal cycler and
an ABI Prism 377 automated sequencer according to the
manufacturer’s instructions. PCR and Northern analysis were
carried out according to standard protocols and signals on
Northern blots were quantiﬁed using a Phosphorimager
(Amersham).
Protein analysis
For Western blots, whole cell lysates were separated by
SDS-PAGE and electroblotted using standard protocols.Anti-
bodies used included rabbit polyclonal a-NPT (1:2000),
mouse a-cMyc 9E10 (1:2000), mouse monoclonal a-Xpress
(1:5000), rabbit polyclonal a-GFP (1:4000) and rabbit poly-
clonal a-VSG2 (1:20000). Western blot signals were detected
using an ECL + Kit (Amersham) according to the manufac-
turer’s instructions. Immunoﬂuorescence microscopy was
carried out as described (Alsford et al., 2007). Brieﬂy, cells
were ﬁxed with 2% formaldehyde for at least 1 h and washed
twice with PBS and once with 1% BSA (in H2O) before drying
on slides for at least 3 h. Cells were then permeablized with
0.5% Triton X-100 for 10 or 20 min and blocked in 30% FBS
for 5 min. Indirect detection of GFP and MYC epitopes was
carried out using a-GFP (1:200) and a-cMyc 9E10 (1:500)
using standard protocols. Samples were mounted in Vectash-
ield (Vector Laboratories) containing the DNA counterstain,
4′,6-diamidino-2-phenylindole. Slides were analysed on a
Nikon Eclipse E600 epiﬂuorescence microscope. Phase and
ﬂuorescence images were captured using a Coolsnap FX
(Photometrics) CCD camera and processed in Metamorph
5.0 (Universal Imaging) and Photoshop Elements 2.0
(Adobe).
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